共 50 条
- [6] Rational design of TGFbRII dominant negative armored GPC3 CAR-T cells for the treatment of hepatocellular carcinoma JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
- [10] Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy FRONTIERS IN IMMUNOLOGY, 2022, 13